top of page
Bridge2Food Europe 2026
Fi Europe 2026
ADM Sav Meats MPU | Mar-Apr 2026
biotech
Crunchtime podcast: Exploring the impact of the new C-Label and F-Label
Crunchtime podcast: Exploring the impact of the new C-Label and F-Label

We explore the impact of V-Label's new certifications for foods made with advanced cell cultivation and fermentation technologies.

Exclusives
Debut develops animal-free carmine following enzyme discovery milestone
Debut develops animal-free carmine following enzyme discovery milestone

Debut has announced a significant breakthrough in animal-free bioproduction of the traditionally beetle-derived red colourant, carmine.

Ingredients
Äio scales fermentation-based fat and oil production to 10,000 litres
Äio scales fermentation-based fat and oil production to 10,000 litres

Äio has successfully scaled production of its fermentation-made fats and oils to an industrial-level batch of 10,000 litres.

Ingredients
Standing Ovation and Ajinomoto forge partnership to advance alt-protein production
Standing Ovation and Ajinomoto forge partnership to advance alt-protein production

Standing Ovation, a French biotech company, has announced a partnership with Ajinomoto Foods Europe to advance alt-protein production.

Technology
Cradle raises $73m in Series B funding round for AI-powered protein engineering technology
Cradle raises $73m in Series B funding round for AI-powered protein engineering technology

Cradle has raised $73m in Series B funding to address rising demand for its AI-powered protein engineering technology.

Funding & investments
Start-up spotlight: NoPalm Ingredients
Start-up spotlight: NoPalm Ingredients

This time, we speak to NoPalm Ingredients, a Dutch biotechnology company that is on a mission to produce palm oil without palm trees.

Exclusives
LanzaTech expands into producing nutritional protein from CO2
LanzaTech expands into producing nutritional protein from CO2

US biotech company LanzaTech has announced plans to expand into the alternative protein market, producing a microbial protein from CO2.

Cell-based
Helaina raises $45m to speed-up commercialisation of human bioactive proteins
Helaina raises $45m to speed-up commercialisation of human bioactive proteins

US biotech start-up Helaina has raised $45 million in a Series B funding round led by investment firm Avidity Partners.

Cell-based
  • Page 2
bottom of page